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Abstract
For self-renewal, embryonic stem cells (ESCs) require the expression of specific transcription factors accompanied by a
particular chromosome organization to maintain a balance between pluripotency and the capacity for rapid differentiation.
However, how transcriptional regulation is linked to chromosome organization in ESCs is not well understood. Here we
show that the cohesin component RAD21 exhibits a functional role in maintaining ESC identity through association with the
pluripotency transcriptional network. ChIP-seq analyses of RAD21 reveal an ESC specific cohesin binding pattern that is
characterized by CTCF independent co-localization of cohesin with pluripotency related transcription factors Oct4, Nanog,
Sox2, Esrrb and Klf4. Upon ESC differentiation, most of these binding sites disappear and instead new CTCF independent
RAD21 binding sites emerge, which are enriched for binding sites of transcription factors implicated in early differentiation.
Furthermore, knock-down of RAD21 causes expression changes that are similar to expression changes after Nanog
depletion, demonstrating the functional relevance of the RAD21 - pluripotency transcriptional network association. Finally,
we show that Nanog physically interacts with the cohesin or cohesin interacting proteins STAG1 and WAPL further
substantiating this association. Based on these findings we propose that a dynamic placement of cohesin by pluripotency
transcription factors contributes to a chromosome organization supporting the ESC expression program.
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Introduction
The cohesin complex, consisting of four core subunits (SMC1a,
SMC3, RAD21 and STAG (STAG1 or STAG2)), is important for a
variety of biological processes including chromosome segregation,
DNA-damage repair and chromosome morphology [1,2,3,4,5,6]. A
model of a ring-like structure suggests that cohesin can encircle DNA,
thereby physically connecting different DNA strands for these diverse
biological processes. Cohesin functions are supported by accessory
proteins such as the cohesin loading factor NIPBL [7,8] as well as the
cohesin maintenance proteins WAPL [9,10] and PDS5 [11,12].
Recent studies have extended the canonical functions to a role of
cohesin in gene regulation [13,14,15,16,17,18,19,20]. For instance,
experiments have revealed that cohesin is loaded onto chromatin long
before sister-chromatid cohesion is established [14]. Furthermore,
cohesin is present in postmitotic cells and only a small amount is
actually needed formitosis [21,22]. Association of cohesinwith human
developmental disorders occurring relatively late in development also
proposed a functional role in gene expression regulation, because
mutations that only affect sister-chromatid cohesion would predict to
cause lethality early in development. However, disorders displaying
mutations in the cohesin network termed cohesinopathies do not show
severe defects in sister chromatid cohesion [14,23,24,25]. Finally, the
prominent co-localization with the chromatin boundary factor CTCF
suggests a role of cohesin in chromatin mediated gene regulation
[14,24,26,27,28,29,30,31]. However, how cohesin contributes to the
execution of specific gene expression programs is not well understood.
Interestingly, we and others recently identified cohesin subunits
in RNAi ESC screens as factors that are required to maintain Oct4
expression [32,33]. ESCs present an excellent cellular system to
investigate a potential role of cohesin in gene regulation because
the transcriptional repertoire that maintains ESC identity has been
studied extensively and conditions for an exit from the self-renewal
program are well defined.
Results
An organizational principle of RAD21 at CTCF binding
sites
To gain insights into a potential role of cohesin in ESC biology,
we performed a global DNA-binding survey of RAD21, a core
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component of the cohesin complex. We used a RAD21 BAC-GFP
tagged ESC line and performed chromatin immunoprecipitation
followed by massive parallel DNA sequencing (ChIP-seq) employ-
ing a high-affinity GFP-antibody. Applicability and specificity of
the BAC tagging approach for generic assays has been
demonstrated previously [34,35] and has been specifically
validated here for RAD21 (Fig. S1). For analysis of the ChIP-seq
data set, we first subtracted the IgG ChIP-seq data from the
Rad21 ChIP-seq data and employed the MACS algorithm
(1.4.0beta version) to call binding peaks. With a cut-off p-value
of 10e-5, we identified 15311 specific RAD21 binding sites (Table
S1, Fig. S2) unmasking a characteristic binding pattern of RAD21
in ESCs.
Consistent with genome-wide binding studies for other cohesin
subunits [24,28], inspection of the bound sequences did not reveal
a RAD21 specific consensus sequence, indicating that the cohesin
complex is not a sequence specific DNA binding complex. Instead,
we identified the CTCF binding motif in 93% of all RAD21
binding sites. Cohesin has been shown to co-localize with the
insulator protein CTCF, where it most likely contributes to
chromosome organization via DNA loop formation between
distant genomic regions [24,30,36]. To test whether this co-
localization is indeed present in ESC, we also conducted ChIP-seq
analysis with a validated CTCF BAC-GFP tagged cell line (Fig.
S1). Using the same parameters for peak detection, we identified
33788 CTCF binding sites in ESCs. We compared the RAD21
binding pattern to the CTCF binding sites in ESC and observed a
remarkable overlap of the binding patterns of these two factors,
with 73% of the RAD21 binding sites co-localizing with CTCF
binding sites (Fig. 1A).
Close inspection of the RAD21 and CTCF peaks revealed that
RAD21 typically does not exactly overlap with the CTCF binding
position. Instead, RAD21 peaks were slightly shifted in respect to
the CTCF summits (Fig. 1B). For a comprehensive analysis of this
observation, we computationally determined the binding sites
integrating all RAD21 peaks and calculated the distance to the
closest CTCF binding motif in a strand specific manner. This
analysis validated our initial observation and uncovered a
directional placement of RAD21 59 of the CTCF motif (Fig. 1C).
Thus, our study reveals an hitherto unknown organizational
principle of RAD21 binding close to CTCF sites in vivo.
CTCF-independent RAD21 binding sites preferentially
co-localize with key pluripotency related transcription
factors
Despite the high overlap of RAD21 and CTCF binding, we also
identified 4087 (26.7%) RAD21 binding sites that did not co-
localize with CTCF in ESCs (Fig. 1A and Table S2). This result is
consistent with previous studies in somatic cells, where non-CTCF
bound sites for different cohesin components were reported
[14,28,30]. Closer inspection of these binding sites revealed that
3420 (83.7%) of the non-CTCF bound binding sites contained the
CTCF motif, indicating that they are either not bound by CTCF
in ESCs, even though the binding motif is present or that these
sites were not detected during ChIP-sequencing. To generate a list
of unambiguous CTCF negative RAD21 binding sites we removed
these sites, leaving 667 reassessed CTCF independent RAD21
binding sites, which we define as motif and CTCF-independent
RAD21 binding sites (MCIB). To investigate whether other
binding sites could be detected in this MCIB subset, we performed
a motif search analysis in the vicinity (150bp) of MCIB RAD21
peak summits (Table S2). Strikingly, this analysis showed an
enrichment for DNA motifs that are known binding sites of
key pluripotency transcription factors (Fig. 2B). In particular,
bona-fide binding motifs for Oct4 (encoded by Pou5f1), Nanog,
Sox2, Klf4, and Esrrb were enriched at MCIB over all RAD21
binding sites. To investigate whether RAD21 does indeed co-
localize with pluripotency transcription factors at these sites in vivo,
we compared our data with published ChIP-seq data [37] of
pluripotency transcription factors in ESCs. Remarkably, a
significant overlap of MCIB RAD21 binding sites and the ESC
transcription factors with a clear enrichment of ESC transcription
factors at these particular MCIB sites over all RAD21 sites was
observed (Fig. 2, Table S3). Moreover, many of the MCIB RAD21
sites co-localized with Multiple Pluripotency Transcription Factor-
Binding loci (MTL), from which around 40% were reported to be
located in ESC intergenic regions [37] (Fig. 2A, Table S3).
Interestingly, the MCIB RAD21 binding sites did not show a
characteristic directional binding to the pluripotency transcription
factor motifs as seen for CTCF co-bound sites.
RAD21 and other cohesin subunits are required to
maintain ESC identity
The co-localization of RAD21 with pluripotency transcription
factors prompted us to further investigate the functional role of
RAD21 and other cohesion subunits in ESC maintenance.
Because of its essential role during cell division, complete removal
of cohesin causes cell death [38,39,40]. However, knock-down of
cohesin complex components by RNAi has been used to
investigate non-essential functions of the complex for instance in
MCF-7 cells [28]. These experiments revealed that cells could
divide and survive with reduced levels of cohesin proteins [22]. As
in MCF-7 cells, transfection of ESCs with esiRNAs targeting
RAD21, SMC1a or SMC3 resulted in significant depletion both at
mRNA and protein level (Fig. 3A,B) without causing pronounced
cell death (data not shown). Importantly, ESC colonies lost their
typical compact morphology 72 h post transfection with many flat
and extended cells appearing at the periphery of colonies (Fig. S4),
suggesting loss of pluripotency. Alkaline phosphatase staining
showed a strong reduction of AP-positive cells for knock-down of
all three subunits, verifying the loss of pluripotency and subsequent
differentiation upon cohesin depletion (Fig. 3 C,D, S5A). The loss
of AP expression upon RAD21 depletion was accompanied by a
decrease in expression of pluripotency markers, including Oct4,
Nanog and Myc (Fig. 3E). Conversely, the expression of lineage
markers characteristic for all three germ-layers (ectoderm: Fgf5,
mesoderm: brachyury, endoderm: FoxA2) and trophectoderm
(Cdx2) were strongly upregulated, signifying differentiation of the
cells (Fig. 3F).
To test whether the expression change of pluripotency and early
developmental genes in RAD21 depleted cells is also valid for
other cohesin subunits, we repeated the expression analysis with
SMC1a and SMC3 depleted ESCs and detected similar expression
changes of pluripotency and lineage markers (Fig. S5 B,C).
Although the magnitude of expression changes for some markers
varied, possibly due to experimental variations, differences in
knockdown efficiency or divergence in protein half-life, the overall
concordance of the results were striking, indicating that the
observed phenomena can be attributed to the cohesin complex
rather than RAD21 itself. In summary, physiological expression of
cohesin is required to maintain ESC identity.
Expression changes after RAD21 depletion resemble
Nanog knock-down
To obtain a global view of expression changes, we transfected
ESCs with RAD21 esiRNAs andmeasured expression changes after
48 hours using microarrays. Strong changes of the transcriptome
RAD21 in Embryonic Stem Cell Identity
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were evident (Table S4), supporting a role of RAD21 in ESC gene
regulation. More importantly, many known stem cell maintenance
genes, including Tbx3, Esrrb, Klf4, Fgf4, Nanog and Oct4 were
downregulated (Fig. 4A, S6). In contrast, a large number of
developmental genes from all three germ layers and the trophec-
toderm lineage were upregulated (Fig. 4A, S6). Notably, many genes
associated with known critical ESC maintenance signaling path-
ways, including the TGF-b, Wnt and Notch signaling pathways
were also affected (data not shown). Gene Ontology enrichment
analysis showed that genes associated with cell differentiation and
development were strongly enriched (p.561015) (Fig. 4B), mani-
festing the exit of the pluripotency expression program and
induction of differentiation programs upon RAD21 knock-down.
To place the observed expression changes into context of other
factors, we compared the RAD21 expression profile to published
data [41,42]. Remarkably, the expression profile after RAD21
knock-down was similar to expression changes reported for the
depletion of pluripotency transcription factors (Fig. 4C). Thus,
RAD21 knock-down mirrors expression changes observed after
depletion of pluripotency transcriptional regulators. In particular,
the depletion of RAD21 closely resembled the expression profile
after Nanog knock-down with a Pearson correlation coefficient of
0.4 (Fig. 4D,E). Notably, this correlation coefficient matched or
exceeded a comparison between Nanog and other pluripotency
factors, indicating a particularly tight link between Nanog and
RAD21 depletion (Fig. 4E). This finding, together with the
observed phenotypical consequences upon knock-down and the
observed co-localization at MCIB RAD21 sites suggests that
RAD21 is linked to the maintenance of ESCs through an
association with pluripotency transcription factors.
Figure 1. Organizational principle of RAD21 placement near CTCF binding sites in ESCs. (A): Venn diagram showing the overlap of RAD21
with CTCF binding sites (p,1025). Non-overlapping RAD21 binding sites are separated into CTCF binding independent (3420, named CIB) and CTCF
binding and motif independent sites (667, named MCIB). (B): Examples of ChIP-seq binding peaks indicating a shift of RAD21 and CTCF loci. Vertical
red bars indicate the CTCF binding peak summits. Data show absolute number of reads at the y-axis and chromosome position at the x-axis. (C):
Histogram of distances between RAD21 binding sites and CTCF strand-specific motifs identified RAD21 to be located at CTCF binding sites with
upstream directionality. Black lines are the components of the Gaussian mixture modeling distribution of distances. The solid line indicates the most
dominant distribution and the dashed line indicates a second component of the mixture model. The red bar indicates the RAD21 binding site and the
black ellipse indicates position of CTCF binding motif depicted below.
doi:10.1371/journal.pone.0019470.g001
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Co-localization of RAD21 with pluripotency related
transcription factors at CTCF-independent sites is specific
for ESCs
Functional relevance of RAD21 co-localizing with pluripotency
maintaining transcription factors for ESC identity would suggest
that these binding sites are ESC specific and that RAD21 would
not be found there when cells exit the pluripotency program. To
investigate this assumption, we differentiated LAP-tagged RAD21
ESCs into embryoid bodies (EBs) and performed ChIP-seq using
the same parameters as employed previously for ESCs. With this
analysis, we detected 11022 RAD21 binding sites in EBs.
Interestingly, around half of the 15311 binding sites detected in
ESCs, namely 7012 (45.8%), were also detected in EBs. This result
suggests that many of the RAD21 binding sites are maintained
upon differentiation (Fig. 5A). In support for this observation, a lot
of the unaltered RAD21 binding sites in ESCs are also conserved
in B- and T- cells [24] (data not shown). In sharp contrast, the
majority of the 667 MCIB RAD21 sites including the MTL co-
localizing sites in ESCs had disappeared in EBs, indicating that the
co-localization of RAD21 with pluripotency transcription factors is
specific for ESCs (Fig. 5A–D). At the same time DNA binding motifs
of transcription factors related to early development were now
enriched at the MCIB RAD21 binding sites (Fig. 5B), suggesting
that these transcription factors now cooperate with cohesin to
influence gene expression. As for the MCIB RAD21 binding sites in
ESCs, we did not observe directional binding to transcription factor
motifs (Fig. S3) as seen for CTCF co-bound sites.
Nanog interacts with cohesin proteins STAG1 and WAPL
Because cohesin by itself does not seem to bind DNA sequence
specifically, other mechanisms to place it at specific regions in the
genome must exist. For RAD21 binding at CTCF sites, CTCF is
suggested to localize cohesin via protein-protein interaction with
STAG (SCC3) [30]. In order to gain insight into the mechanism of
Figure 2. MCIB RAD21 binding sites co-localize with key pluripotency related transcription factors. (A) Examples of ChIP-seq results
showing co-localization of MCIB RAD21 binding sites with key ESC specific transcription factors. ChIP-seq data were obtained from previous studies
[37] for the indicated loci in ESCs. MCIB RAD21 sites are highlighted in red and CTCF-overlapping sites are highlighted in blue. (B) Enrichment analysis
of transcription factors in the 150 bp vicinity of MCIB RAD21 binding peak summits over all RAD21 binding peak summits shows overrepresentation
of both DNA binding motifs and real binding of ESC specific transcription factors at MCIB RAD21 sites. MTL (Multiple Transcription Factor loci) are
binding sites with at least two pluripotency transcription factors that co-localize with RAD21. Black bars show enrichment of binding events identified
by ChIP-seq [37] and grey bars show enrichment of DNA binding motifs.
doi:10.1371/journal.pone.0019470.g002
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how cohesin is recruited to the ESC transcription factor binding
sites, we performed a proteomic study on Nanog, the transcription
factor with the highest enrichment score and the most similar
expression pattern changes upon RAD21 depletion. Immunopre-
cipitation of LAP-tagged Nanog protein in Nanog-LAP- and
control wildtype ESCs identified well known interaction partners
of Nanog including Nr0b1, Zfp281, Sall4, Nac1, Gdf3, Sox2 and
Rnf2 and thus validated functionality of the Nanog-LAP ESC line
(Table S5). Interestingly, we also detected the core cohesin protein
STAG1 and the cohesin associated protein WAPL as interaction
partners of Nanog (Fig. 6A). To validate this result, we tested the
interaction of STAG1 with Nanog by co-immunoprecipitation of
Figure 3. Depletion of RAD21 and other cohesin subunits leads to differentiation of ESCs. (A): qPCR analysis of esiRNA knock-down
efficiency for indicated genes (48 h RNAi, n = 3, error bars denote s.d. and *, ** indicate p,0.05 and 0.01 respectively). Transfection of a non-targeting
esiRNA (Luc) was used as a control. Numbers adjacent to the gene names indicate independent, non-overlapping esiRNAs transfected. (B): Western
Blot analysis of esiRNA knock-down efficiency for indicated genes (48 h RNAi; esi-1 and esi-2 indicate independent, non-overlapping esiRNAs
transfected). Transfection of a non-targeting esiRNA (Luc) was used as a control. GAPDH served as a protein loading control. (C): Alkaline phosphatase
staining of ESCs, which had been transfected with esiRNAs targeting RAD21, SMC1a and SMC3 (72 h post RNAi) showed a strong differentiation
phenotype compared to a control (Luc). Nanog depletion served as a positive control for ESC differentiation. Scale bars correspond to 100 mm. (D):
Quantification of alkaline phosphatase staining (n = 3) separated into undifferentiated (green), mixed (yellow) and differentiated colonies (red). (E+F):
qPCR validation of expression changes of (E) stem cell maintenance genes and (F) lineage marker genes upon knock-down of RAD21 (two
independent esiRNAs) and Luc control (48 h RNAi, n = 3, error bars denote s.d. and *, **, *** indicate p,0.05, 0.01 and 0.001 respectively).
doi:10.1371/journal.pone.0019470.g003
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GFP versus an IgG control in Nanog-LAP ESCs as well as in
wildtype ESCs and confirmed the specific interaction in Nanog-
LAP cells (Fig. 6B,C). Collectively, these data indicate that
Nanog may facilitate the placement of cohesin at its binding
sites through an interaction with specific cohesin proteins and
together with similar phenotypical consequences upon knock-
down and co-localizing DNA-regions, suggests cooperativity
between the non-specific DNA-sequence bound (chromatin
organizer) cohesin and the specific DNA-sequence bound
pluripotency transcription factors.
Comparative DNA binding analysis of cohesin sub-units
Recently, the binding pattern of the cohesin subunits SMC1a
and SMC3 were described in ESCs [43]. We re-analyzed these
data sets (two replicates each, Fig. S7) and integrated our RAD21
data using the MACS algorithm (p,1022) to calculate the number
of common cohesin binding sites (Fig. 7A), creating a list of high
confidence common cohesin binding sites in ESCs (Table S7). We
also integrated the different CTCF data sets to determine the
number of common cohesin binding sites that are independent of
CTCF. This analysis identified 16576 common cohesin binding
Figure 4. Gene expression profile upon RAD21 depletion exhibits close analogy to Nanog depletion. (A): Heatmap showing expression
changes of selected developmental and stem cell maintenance genes in four biological replicates (48 h RNAi). (B): Gene Ontology (GO)-term analysis
determined ‘Cell differentiation’ and ‘Development’ as processes to be most overrepresented. (C): Venn diagram showing the overlap of RAD21 with
pluripotency genes Oct4 and Nanog expression profiles after their depletion. (D): Volcano plot demonstrating the remarkable overlap of RAD21 and
Nanog expression profiles upon their depletion. Each dot represents a probe from the RAD21 microarray (averaged over four replicates), blue dots
represent downregulated genes and red dots represent upregulated genes. (E): Bar chart of Pearson’s correlation factors between expression profiles
of Nanog and factors essential for stem cell identity after their depletion. Note that the correlation factor for RAD21 is similar to the correlation factors
for Oct4 and Sox2.
doi:10.1371/journal.pone.0019470.g004
RAD21 in Embryonic Stem Cell Identity
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sites, from which 2020 (12%) sites were independent of CTCF
binding but still exhibit the CTCF motif sequence and 273 (1.7%)
sites that are independent of CTCF binding and do not contain
the CTCF motif sequence (MCIB). This result indicates that the
number of cohesin binding sites that are independent of CTCF is
lower then the number of sites where these proteins co-localize.
This number becomes substantially smaller when also the sites that
still contain the CTCF motif sequence are considered in this
analysis.
Interestingly, the comparative analysis revealed binding sites of
individual subunits that are not shared with other cohesin subunits
(Fig. 7B). This observation raises the possibility that, apart from a
major concordance of core cohesin binding sites, individual
cohesin subunits may bind to DNA in a unique manner. However,
it is also possible that this observation is a result of the different
ESCs and antibodies employed in the different studies or may also
reflect experimental variability in ChIP-seq experiments.
Discussion
Cooperativity between mammalian transcription factors that
bind sequence specific DNA elements and factors that mediate
chromosome conformation have long been proposed, but
molecular details on how they work together have been sparse.
The recent implication of cohesin in regulating chromosome
conformation [20,27,36,44] together with its detection in ESC
identity RNAi screens [32,33] prompted us to investigate the role
of RAD21 in ESCs in more detail. Our genome-wide RAD21
binding survey in ESCs and EBs revealed three modes of RAD21
binding, the conserved and the dynamic CTCF dependent and the
CTCF independent binding mode.
The majority of sites that are co-occupied by CTCF and
RAD21 appear to be conserved in ESCs and in different cell types,
suggesting that they may provide a framework supporting a
general chromosome architecture. Our observation that RAD21
exhibits a characteristic shifted directionality with respect to
CTCF, which we did not observe for pluripotency transcription
factor co-bound sites, might indicate a different functionality of
RAD21 at the CTCF dependent compared to the independent
sites or a different mode of physical interaction with the particular
transcription factors. Physical interaction of cohesin with CTCF
has recently been reported [30], suggesting a direct role of CTCF
in recruiting RAD21 59 of its binding site, although factors that
mediate the placement cannot be excluded. In this context, a
methylation dependent mechanism may account for recruiting
cohesin because CTCF binds DNA in a methylation specific
manner [16]. It will be interesting to further investigate how this
placement is achieved and what relevance it has with respect to
transcriptional insulation and chromosome architecture.
The comparative RAD21 binding analysis in ESCs versus EBs
also uncovered changes in the CTCF dependent RAD21 binding
sites, revealing the dynamic CTCF dependent RAD21 binding
mode mentioned above. The fact that these sites change upon
differentiation indicates that they may be important during
Figure 6. Nanog interacts with STAG1 and the cohesin associated protein WAPL. (A): List of selected proteins identified by mass
spectrometry of Nanog BAC-GFP tagged ESCs. Proteins with their masses, identified number of peptides and significances (student’s t-test) are
shown. The cohesin protein STAG1 and cofactor WAPL are highlighted in yellow. (B): Western blot analysis after co-immunoprecipitation of GFP in
Nanog BAC-GFP tagged ESC detected the bait (Nanog-LAP) using a GFP-antibody. Precipitation with an IgG antibody served as a control. (M=protein
marker, kDa) (C): Western blot analysis after co-immunoprecipitation of GFP in Nanog BAC-GFP tagged ESCs and wildtype ESCs revealed a specific
interaction with STAG1 in the GFP-IP. No interaction was detected in wildtype ESCs (M=protein marker, kDa).
doi:10.1371/journal.pone.0019470.g006
Figure 5. MCIB RAD21 binding sites are predominantly specific for ESC and disappear in EBs. (A): Venn diagram displaying the number
of RAD21 binding sites specific for ESCs and EBs as well as the number of overlapping binding sites. The red circle separates the MCIB binding sites.
(B): Enrichment analysis of transcription factors at MCIB over all RAD21 binding sites in EBs indicate upregulation of developmental- and
downregulation of ESC specific transcription factors. Black bars show enrichment of binding events identified by ChIP-seq and grey bars show
enrichment of binding motifs (*, **, *** indicate Fisher’s exact test p,0.05, 0.01 and 0.001, respectively). (C): Examples of ChIP-sequencing peaks in
ESCs and EBs showing the disappearance of MCIB RAD21 binding sites that co-localize with ESC transcription factors. MCIB RAD21 sites are
highlighted in red and CTCF-overlapping sites are highlighted in blue. (D): Validation of selected loci by conventional ChIP followed by quantitative
real-time PCR (n = 3, error bars denote s.d. and *, **, *** indicate p,0.05, 0.01 and 0.001, respectively). Black bars show fold enrichment in ESCs and
grey bars show enrichment in EBs. Labels indicate the chromosome positions of the target loci and the closest gene indicated in brackets.
doi:10.1371/journal.pone.0019470.g005
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development. Since the epigenetic chromatin state changes with
differentiation [45], the previously described DNA methylation
dependency of CTCF binding [16] may account for the change of
dynamic CTCF dependent binding of RAD21 in EBs. To further
investigate this aspect, it will be interesting to compare the
epigenetic changes with CTCF and cohesin binding sites during
ESC differentiation in the future.
Probably the most intriguing finding was the identification of
the motif and binding CTCF independent (MCIB) RAD21
binding sites that exhibited enrichment for pluripotency related
transcription factors binding sites. The fact that these sites
disappear in EBs and new binding sites emerge, which are
enriched for early developmental transcription factors suggests
that these sites are functionally relevant for the execution of
developmental expression programs. The expression changes
observed after RAD21 depletion mirroring knockdown of Nanog
further support this notion.
Notably, the number of CTCF independent RAD21 binding
sites in ESCs is considerably lower than reported for other cohesin
subunits, namely SMC1a and SMC3 [43]. However, this is largely
due to the different analysis methods employed and re-analysis of
the data with our parameters also resulted in a much lower
percentage of CTCF independent SMC1 and SMC3 binding sites
including MCIB sites. Moreover, our comparative analysis
revealed binding sites of individual subunits that are not shared
with other cohesin subunits, suggesting that individual cohesin
subunits are found at certain DNA sites. Whether this observation
indeed reflects independent subunit binding or instead is a result of
the different ESCs and antibodies employed or experimental
variability in ChIP-seq experiments needs to be determined in the
future. Nonetheless, independent of the analysis method em-
ployed, the cumulative data suggests that RAD21 together with
the other cohesin proteins maintains ESC identity by connecting
functionally relevant DNA elements. Thereby, it creates an ESC
chromatin architecture that supports ESC specific gene expression
programs.
With several ChIP-chip and ChIP-seq data sets published
[14,24,28,43], a significant repertoire of cohesin and CTCF
binding sites in various cell types is now available. The
comparative analysis of CTCF and cohesin binding data published
with this manuscript should provide a high confidence list for
future studies. Eventually, an integrated analysis also from
differentiated cells should allow a refinement of the cohesin
binding patterns and may ultimately help to build a roadmap for
chromosome architecture during development.
A remaining question is how the transcription factors interact
with the cohesin proteins implicated in chromosome conforma-
tion. The study of Kagey and colleagues showed interaction of the
cohesin loading factor NIPBL with the mediator complex [43], of
which the latter phenocopied cohesin in terms of ESC identity. In
Figure 7. Integrated analysis of RAD21, SMC1 and SMC3 binding sites in ESCs. (A): Common binding sites of RAD21, SMC1 and SMC3 [43]
and the overlap with common CTCF sites are shown. The number of binding sites are depicted for each experiment and the overlap of the data is
presented in the intersection. The green dashed line separates cohesin sites that are independent of CTCF from sites that are independent of CTCF
binding and do not contain the CTCF motif sequence (MCIB, shown in red). (B): Examples of ChIP-sequencing peaks in ESCs showing co-localization
of all sequenced cohesin subunits and localization of individual subunits only. Areas of interest are marked in blue and called cohesin subunit binding
sites are boxed in red. Chromosomal locations of the peaks are indicated above the graphs. Note the absence of peaks for RAD21 and SMC3 in the
second, and the absence of peaks for SMC1 and SMC3 in the third example, respectively.
doi:10.1371/journal.pone.0019470.g007
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the study of Tutter and colleagues an interaction of the mediator
component Med12 with Nanog was described [46]. Additionally,
they found that Med12 and Nanog exhibited similar phenotypes,
gene expression profiles and patterns of genome distribution.
Another study revealed protein-protein interaction of Oct4 with
SMC1a [47]. Our data suggest that Nanog may facilitate the
placement of cohesin at its binding sites through an interaction
with STAG1 and/or WAPL. Considering the fact that cohesin co-
localizes at multiple transcription factor loci, the direct interaction
of Oct4 with SMC1a and Nanog with STAG1 and WAPL may
support the pluripotency transcription factor mediated placement
of cohesin at CTCF-independent binding sites.
Collectively, these data suggest a complex interplay of the
different co-localizing protein complexes and strongly indicate that
these factors act in concert to maintain embryonic stem cell
identity. However, a possible hierarchy of events and functions for
the cooperativity of RAD21 and other cohesin subunits with
pluripotency transcription factors at these sites needs future
investigations. A detailed dissection of interactions between
cohesin proteins and pluripotency transcription factors will
certainly enhance our understanding of transcriptional regulation
in light of higher order chromosome architecture.
Methods
Cell culture
Feeder-free mouse R1/E ESC were maintained on gelatin-
coated dishes in DMEM (GLUTAMAX high-glucose, Gibco)
media supplemented with 15% FBS (Gibco), 0.055 mM b-
mercaptoethanol (Gibco), 16 MEM non-essential amino acids
(Invitrogen), 5000 u/ml penicillin-streptomycin (Invitrogen) and
16 ng LIF (in house production as previously described [32])/
250 ml medium.
BAC transgenomics
BACs harbouring the genes of interest were obtained from the
BACPAC Resource Center (http://bacpac.chori.org; BAC-IDs:
RP23-375K15 (RAD21), RP23-236B2 (CTCF) and RP24-230P19
(Nanog)). A LAP cassette [48] was inserted as a C-terminal fusion
using recombineering technology [49] (Gene Bridges). Isolated
BAC DNA was transfected and selected for stable integration as
described [34]. Resistant clones were additionally sorted for GFP-
positive cells by FACS. Correct protein size and localization was
verified by Western blot and immunofluorescent staining as
described previously [34].
Embryoid body differentiation
RAD21-LAP tagged ESC were differentiated into embryoid
bodies for 12 days using the hanging drop method according to the
protocol of Linda C. Samuelson and Joseph M. Metzger, Cold
Spring Harb Protoc 2006.
RNA interference
Mouse esiRNAs were produced as described previously [50].
Primer sequences are listed in Table S6. EsiRNA transfection was
performed for 48 h using Lipofectamine2000 (Invitrogen) accord-
ing to the manufacture’s instructions with 800 ng esiRNA, 2 ul
transfection reagent and 80000 cells per well in 12-well plates.
Western Blot
Cells were harvested and 10–20 ug of total protein extracts were
separated on NuPage 4–12% Bis-tris gels (Invitrogen) and blotted
on nitrocellulose membranes (Millipore). Membranes were probed
with antibodies against GFP (MPI-CBG antibody and protein
production facility, 1:10000), SMC1 and SMC3 (Bethyl Labora-
tories, Inc., Cat.No. A300-055A and A300-060A, 1:5000) and
RAD21 (Santa Cruz, sc-56208, 1:500). GAPDH (Novus Biolog-
icals NB300-221, 1:50.000) was used as a loading control.
Alkaline Phosphatase staining
Three days post RNAi, cells were fixed with 4% paraformal-
dehyde (Sigma), rinsed in PBS and stained using Alkaline
Phosphatase Red Microwell substrate (Sigma). Images were
acquired with a Canon Power Shot G11 digital camera on the
Olympus CKX41 microscope.
Based on the staining intensity, percentages of differentiated,
half-differentiated and undifferentiated cells were determined by
counting.
RNA isolation, cDNA synthesis and quantitative real-time
PCR
For isolation of total RNA the RNeasy Mini Kit (Qiagen) was
used according to the manufacture’s protocol including a DNaseI
digest. Reverse transcription of 0.5–1 ug RNA was performed
using Oligo-dT12–18 and Superscript III kit (Invitrogen). Quanti-
tative real-time PCR analysis was carried out using SYBR green
master mix (Abgene) and the MxP3000 detection system
(Stratagene). Samples were run in triplicate and transcript levels
were calculated according to the DDct method with normalization
to CyclophilinB. Primer sequences are listed in Table S6.
Immunoprecipitation and mass spectrometry
Immunoprecipitation reactions were carried out with nuclear
extracts from Nanog-LAP ESC as well as wildtype ESC and
subjected to shotgun mass spectrometry as previously described
[51]. For co-immunoprecipitation analysis, nuclear extracts of
Nanog-LAP ESC or wildtype ESC were prepared using nuclear
extraction reagents (Pierce) and precipitated using a GFP-antibody
(MPI-CBG antibody facility). For the Nanog-LAP ESC line, an
additional IgG isotype control antibody (Dianova) was used.
Western blot detection was performed using GFP (11814460001,
Roche) and STAG1 (sc-54515, SantaCruz) antibodies.
Microarray analysis
Cells were harvested two days post RNAi and 250 ug of isolated
total RNA was labeled with the One-Cycle Target Labeling and
Control Reagent Package (Affimetrix) as described in the
manufacture’s instructions. Probes from 4 biological replicates of
RAD21 and Luc RNAi were hybridized on Mouse Genome
430.2.0 arrays (Affimetrix). Image data were analyzed with the
GeneChip Operation Software applying Affimetrix default
settings. Expression changes were determined by a parametric
analysis of variance (ANOVA) after RMA normalization with
respect to the probe GC content using Partek Genomics Suite 6.4
(6.09.0129) (Table S4).
Gene Ontology analysis was performed using GenCoDis 2.0
[52,53].
For calculation of Pearson’s correlation factor, published
microarray data were used [41,42].
ChIP and ChIP-sequencing
RAD21-LAP ESC were crosslinked with 1% formaldehyde for
10 min at room temperature and crosslinking was quenched with
125 mM glycine. Sonicated chromatin with an average size of
500 bp was immunoprecipitated over night using a GFP-antibody
(MPI-CBG antibody facility) and control IgG-antibody (Dianova)
and immobilized on G-sepharose (GE Healthcare). Specificity of
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the GFP-antibody has been validated before (Poser et al. 2008,
Fig. S1). Eluates were reverse crosslinked followed by RNA and
protein digestion. Quantitative real-time PCR analysis was
performed with 3 biological replicates of purified DNA. Relative
occupancy values were calculated as fold enrichment over control-
IgG (or as percent of input recovery occupancy) and normalized to
RPL19. Primer sequences are listed in Table S6.
For sequencing, 20 ng of the immunoprecipitated DNA was
used to generate the ChIP-seq library according to the
manufacture’s protocol (Illumina) and sequenced with the
Genome Analyzer II (Illumina).
Peak calling
Peak calling was performed using MACS 1.4beta [54] with the
following settings for the RAD21 data: mfold = 8, bw=150 and a
p-value threshold of 1024, and with the following settings for the
previously generated data [37] : mfold = 8, bw= 150 and a p-value
threshold of 1025. Prior peak detection, ChIP-seq fragment
coordinates from CTCF, Pou5f1, Nanog, Sox2, Klf4 and Esrrb
ChIP-seq data [37] were converted into Mouse NCBI genome
build 37 (mm9) using the UCSC liftOver tool [55].
Gene loci identification and genomic distribution
PINKTHING (http://pinkthing.cmbi.ru.nl) software was used
for assigning sites to the nearest gene and to determine genomic
distribution of identified binding sites. Peak locations were
visualized using the University of California Santa Cruz (UCSC)
genome browser.
All sequence analyses were conducted based on the Mus
musculus NCBI m37 genome assembly (mm9; July 2007) accessed
from Ensembl.
Motif analysis
Sequences from a range of 150 bp around peak summits were
extracted with BEDTools package (http://code.google.com/p/
bedtools) and used as a basis for further search of occurrences of
known transcription factor binding motifs from the JASPAR
database [56]. The search was performed using FIMO tool from
the MEME suite [57]. Motif occurrences with a p-value not
exceeding 1025 were considered significant. Gaussian mixture
modeling of distances between binding sites and motifs was
performed with R package mclust (Fraley & Raftery, 2002).
RAD21 binding peaks that were not overlapping with any of the
CTCF peaks, were named CTCF independent RAD21 binding
sites (CIB). Peaks that were not bound by CTCF and did not
contain the CTCF binding motif in the 150 bp vicinity of the peak
summits were considered motif and CTCF binding independent
binding sites (MCIB). The binding site and the motif enrichment
p-values were determined with Fisher’s exact test. Enrichments
were calculated using all RAD21 binding sites as background.
Accession number
MIAME compliant microarray and sequencing data from this
study have been deposited in the MIAME compliant database
GEO with the accession number GSE24030.
Supporting Information
Figure S1 Validation of BAC-GFP tagged ESC lines and
GFP-antibody for ChIP-sequencing. (A): Immunostaining of
RAD21 and CTCF BAC-GFP ESC stably expressing RAD21-
LAP or CTCF-LAP confirmed nuclear localization. In the merged
picture, GFP (LAP tagged protein) is shown in red, a-Tubulin in
green and DNA (DAPI) in blue. Scale bar equals 20 mm. (B):
Western blot analysis of RAD21 and CTCF BAC- GFP ESC
depleted in RAD21 and CTCF, respectively. Two independent
esiRNAs and control esiRNA (Luc) were used. GAPDH
expression served as protein loading control. (C): Western blot
analysis of RAD21-LAP immunoprecipitation using GFP-anti-
body to confirm antibody specificity. Co-immunoprecipitation of
the cohesin complex members SMC1a and SMC3 support
functionality of the RAD21 BAC transgenic ESCs. (D): ChIP of
RAD21-LAP cells transfected with control (Luc) and RAD21
esiRNA. Enrichment of selected MCIB sites that appertain to
indicated genes was quantified by qPCR and confirmed reduced
signals upon RAD21 depletion (n = 2, error bars denote s.d.).
(TIF)
Figure S2 Identification of RAD21 binding sites and
their genome distribution. (A): Table shows the number of
identified binding sites using MACS algorithm in dependency of
the p-value. Numbers are listed for RAD21 and IgG ChIP-
samples. Binding sites detected with the p-value of 10e-5 were used
for further analysis. (B): Genome distribution of RAD21 binding
sites indicated that the majority of RAD21 sites is located in
introns and far distant (.25 kb) from the transcriptional start site.
(C): De novo motif analysis in the 150 bp vicinity of RAD21 peak
summits did not reveal a RAD21 specific consensus sequence.
Search for known DNA binding motifs in the 150 bp vicinity of
peak summits using Jaspar database identified the CTCF motif to
be the most abundant. (D–E): CTCF ChIP-seq data analysis
according to A–C.
(TIF)
Figure S3 Motifs present in the vicinity of RAD21
binding sites apart from CTCF do not exhibit binding
directionality. Motifs in the vicinity of RAD21 apart
from CTCF do not exhibit directionality. The histogram
plot of distances between RAD21 binding site and FoxI1 motif
sequence in 59 to 39 strand direction does not exhibit directionality
of RAD21 binding. Black lines are the components of the
Gaussian mixture modelling distribution of the distances. Solid
lines indicate the most dominant distributions. The red bar
indicates RAD21 binding site and the black ellipses indicate
expected positions of FoxI1 binding sites.
(TIF)
Figure S4 Depletion of cohesin strongly changes ESC
morphology. ESC transfected with esiRNAs against RAD21 (2
independent esiRNAs), SMC1a and SMC3 exhibit strong change
in morphology 72 h post RNAi compared to non-targeting control
(Luc). Depletion of Nanog served as a positive control for ESC
differentiation. Scale bars correspond to 100 mm.
(TIF)
Figure S5 Depletion of SMC1a and SMC3 reflects
expression changes upon RAD21 knock-down. (A): Alka-
line phosphatase staining of ESCs, which had been transfected
with secondary esiRNAs targeting RAD21, SMC1a and SMC3
(72 h post RNAi). Nanog depletion and a non-targeting control
(Luc) served as a positive and negative control for ESC
differentiation, respectively. Scale bars correspond to 100 mm.
(B+C): qPCR result of detected expression changes in (B) stem cell
maintenance genes and (C) lineage marker genes upon knock-
down of SMC1a and SMC3 versus a Luc control (48 h RNAi,
n = 3, error bars denote s.d. and *, **, *** indicate p,0.05, 0.01
and 0.001, respectively).
(TIF)
Figure S6 Validation of microarray gene expression
results. Diagram shows qPCR based confirmation of up- and
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downregulation of selected developmental and stem cell mainte-
nance related genes identified in the RAD21 microarray gene
expression array (48 h RNAi, n= 3, error bars denote s.d. and
*, **, *** indicate p,0.05, 0.01 and 0.001, respectively.
(TIF)
Figure S7 Re-analysis of SMC1 and SMC3 ChIP-seq
data. Analysis of the SMC1, SMC3 and CTCF DNA binding
data. [43] and determination of the overlaps of the individual
experiments is shown using MACS 1.4beta (p,1025). Numbers of
binding sites are presented for the individual experiments,
calculating intersections of each of the two replicates to define
CTCF overlapping and independent binding sites. The green
dashed line separates cohesin sites that are independent of CTCF
binding from sites that are independent of CTCF binding and do
not contain the CTCF motif sequence (MCIB, shown in red).
(TIF)
Table S1 RAD21 binding sites in ESCs and EBs.
(XLS)
Table S2 Enrichment analysis of transcription factor binding
motifs at RAD21 binding sites in ESCs and EBs.
(XLS)
Table S3 Enrichment analysis of RAD21 co-localizing with
ESC transcription factor binding sites in ESCs.
(XLS)
Table S4 Gene expression microarray data of RAD21 depleted
ESCs.
(XLS)
Table S5 List of Nanog interacting proteins identified by mass
spectrometry.
(XLS)
Table S6 Primer sequences for esiRNA production, qPCR and
ChIP.
(XLS)
Table S7 High-confidence cohesin binding sites.
(XLS)
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